from Great Game India:
House investigators on the Energy and Commerce Committee released a 73-page report detailing how NIH officials, including Fauci, misled the media and Congress about risky gain-of-function research involving viruses.
A 73-page report (pdf below) detailing NIH officials’ deceit to the media and withholding of information from Congress regarding risky research involving gain-of-function viruses was made public by House investigators on the Energy and Commerce Committee yesterday. These most recent disclosures come after it was revealed last week that Tony Fauci had misled the New York Times over his participation in a Nature Medicine article that developed the idea that the pandemic could not have originated in a Wuhan, China, lab that Fauci personally funded.
TRUTH LIVES on at https://sgtreport.tv/
The House launched the probe in response to a Science Magazine article published in September 2022 detailing the risks posed by the monkeypox virus, which is spreading around the world and can adapt to humans to become more deadly or contagious. Science Magazine was informed by Bernard Moss, a seasoned poxvirus researcher at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health that monkeypox adapts to multiply more quickly in people.
Science reported that Moss had started gain-of-function experiments, in which genes from different variations are switched out, to determine why some are more transmissible or harmful than others.
MOSS HAS BEEN TRYING FOR YEARS TO FIGURE OUT THE CRUCIAL DIFFERENCE BETWEEN TWO VARIANTS OF MONKEYPOX VIRUS: CLADE 2, WHICH UNTIL RECENTLY WAS FOUND ONLY IN WEST AFRICA AND IS NOW CAUSING THE GLOBAL OUTBREAK, AND CLADE 1, BELIEVED TO BE MUCH DEADLIER, WHICH HAS CAUSED OUTBREAKS IN THE DEMOCRATIC REPUBLIC OF CONGO FOR MANY DECADES. HE’S FOUND THAT CLADE 1 VIRUS CAN KILL A MOUSE AT LEVELS 1000 TIMES LOWER THAN THOSE NEEDED WITH CLADE 2. TO FIND OUT WHY, MOSS AND HIS COLLEAGUES SWAPPED DOZENS OF CLADE 2 GENES, ONE AT A TIME, INTO CLADE 1 VIRUS, HOPING TO SEE IT BECOME LESS DEADLY, BUT WITH NO LUCK SO FAR. NOW, THEY ARE PLANNING TO TRY THE OPPOSITE, ENDOWING CLADE 2 VIRUS WITH GENES FROM ITS DEADLIER RELATIVE.
When Moss revealed that he intended to introduce genes from the more lethal clade 1 monkeypox strain into the more prevalent and spread clade 2 monkeypox virus, scientists expressed concern about the study’s potential risks in a follow-up article published in Science Magazine.
However, Ohio State University researcher Linda Saif expressed concern to Science Magazine’s Jocelyn Kaiser about how too restrictive laws could “greatly impede research into evolving or emerging viruses” and divert attention from domestic research to foreign countries where laws are either less stringent or nonexistent. Strangely enough, I had previously revealed that Saif had assisted in the preparation of a ghostwritten essay from Wuhan Institute of Virology’s Shi Zhengli from February 2020, which referred to the potential for a lab mishap at Wuhan as a “conspiracy.”
Later, Science Magazine’s Kaiser modified her article to clarify that Moss’s research would exclusively focus on clade 2a monkeypox virus, not clade 2b, citing a clarification from Moss’s NIAID.
Eight months later, reporter Helen Branswell for STAT News said that NIAID researcher Bernie Moss was the object of Republican “targeting” and that he had never suggested continuing the risky viral research.
BUT A SPOKESPERSON FOR NIAID TOLD STAT IN LATE MAY THAT THERE HAD BEEN NO FORMAL PROPOSAL FROM MOSS TO DO THE RESEARCH AND THE INSTITUTION HAD NO PLAN TO PROCEED WITH THE STUDY.
“House Republicans want to interrogate poxvirus scientist Bernie Moss—who has been at NIH for 57 years—for work he did not do,” Branswell then wrote on X.
The reports from Branswell of STAT and Kaiser of Science Magazine are also untrue.
House investigators note in their report that Moss released a preprint stating he had already started research using clade 2a and planned study with clade 2b, weeks after NIAID told Science Magazine’s Kaiser that Moss’s planned monkeypox research concerned clade 2a, not clade 2b monkeypox.
Read More @ GreatGameIndia.com
